Phase 1, Open-Label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer during Surgical Procedures


Awarded By

Total Award Amount

  • 0.00
  • Direct Costs

  • 0.00
  • Sponsor Award Id

  • Contributor

  • Anthony Morlandt D.D.S., M.D.   Investigator  
  • Benjamin Greene   Investigator  
  • Garima Agarwal   Investigator  
  • Jason Warram   Investigator  
  • Kirk Withrow   Investigator  
  • Lisle Nabell M.D.   Investigator  
  • William Carroll M.D.   Principal Investigator